The Experience of Adults With Attention-Deficit/Hyperactivity Disorder in 2021 During the COVID-19 Pandemic: The UNCOVER Study.
Saved in:
| Title: | The Experience of Adults With Attention-Deficit/Hyperactivity Disorder in 2021 During the COVID-19 Pandemic: The UNCOVER Study. |
|---|---|
| Authors: | Raveendran S; PatientsLikeMe LLC, Boston, Massachusetts.; Corresponding Author: Subhara Raveendran, PhD, PatientsLikeMe LLC, 6 Liberty Square, Suite 2602, Boston, MA 02109 (subhara.r@gmail.com)., Burke MC; PatientsLikeMe LLC, Boston, Massachusetts., Klahn K; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts., McCue M; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts., Roy A; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts., Martin M; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts., Sarkey S; Takeda Pharmaceuticals USA, Inc, Lexington, Massachusetts. |
| Source: | The primary care companion for CNS disorders [Prim Care Companion CNS Disord] 2023 Jul 13; Vol. 25 (4). Date of Electronic Publication: 2023 Jul 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Physicians Postgraduate Press Country of Publication: United States NLM ID: 101547532 Publication Model: Electronic Cited Medium: Internet ISSN: 2155-7780 (Electronic) Linking ISSN: 21557780 NLM ISO Abbreviation: Prim Care Companion CNS Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2155-7780 |
|---|---|
| DOI: | 10.4088/PCC.22m03474 |
